As new studies emerge investigating the efficacy of GLP-1 medications, particularly in comparison with long-term results for bariatric surgery, this data raises important questions about the future of ...
At least two recent studies have found bariatric surgery more cost-effective, long term, than the pricey glucagon-like peptide 1 (GLP-1) receptor agonist obesity medications. Another recent study ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to nutrition, ...
Bariatric surgery is more cost-effective than GLP-1 RAs for obesity treatment, with lower long-term costs and greater weight loss outcomes. The study found that bariatric surgery led to fewer ...
Bariatric surgery is more cost-effective and offers better long-term outcomes than GLP-1 RAs for obesity and metabolic comorbidities. GLP-1 RAs face challenges like high costs, limited insurance ...
40% of U.S. adults are now considered obese, leading to a dramatic surge in the utilization of the popular but pricey weight-loss drugs PITTSBURGH, Sept. 17, 2025 /PRNewswire/ -- For obese patients, ...
Please provide your email address to receive an email when new articles are posted on . Tirzepatide and semaglutide may be cost-effective weight loss strategies for patients with knee osteoarthritis ...
PHILADELPHIA -- At Roxborough Memorial Hospital in Philadelphia, surgeon Piotr Krecioch has his hands full launching a ...
GLP-1 medications have become game changers for people trying to lose weight, but bariatric surgery is still superior when it comes to total and lasting weight loss, a new study has found. Patients ...
The battle of the bulge! With two strong contenders in the ring — surgery and medications — thousands of patients have had success shedding weight, but is there a clear champion? For many people like ...
Bariatric surgery far outperformed GLP-1 weight loss drugs in a new real-world comparison of more than 50,000 patients. Two years after treatment, surgery patients lost about 58 pounds on average, ...